165 related articles for article (PubMed ID: 38151884)
1. Effect of botulinum toxin type A on muscular temporomandibular disorder: A systematic review and meta-analysis of randomized controlled trials.
Li K; Tan K; Yacovelli A; Bi WG
J Oral Rehabil; 2024 May; 51(5):886-897. PubMed ID: 38151884
[TBL] [Abstract][Full Text] [Related]
2. Botulinum Toxin Type A for Painful Temporomandibular Disorders: Systematic Review and Meta-Analysis.
Machado D; Martimbianco ALC; Bussadori SK; Pacheco RL; Riera R; Santos EM
J Pain; 2020; 21(3-4):281-293. PubMed ID: 31513934
[TBL] [Abstract][Full Text] [Related]
3. Occlusal force characteristics of masseteric muscles after intramuscular injection of botulinum toxin A(BTX - A)for treatment of temporomandibular disorder.
Zhang LD; Liu Q; Zou DR; Yu LF
Br J Oral Maxillofac Surg; 2016 Sep; 54(7):736-40. PubMed ID: 27138229
[TBL] [Abstract][Full Text] [Related]
4. The effects of botulinum toxin A injection on the lateral pterygoid muscle in patients with a painful temporomandibular joint click: a randomized clinical trial study.
Rezazadeh F; Esnaashari N; Azad A; Emad S
BMC Oral Health; 2022 May; 22(1):217. PubMed ID: 35641993
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of botulinum toxin for temporomandibular disorders: A systematic review and meta-analysis.
Saini RS; Ali Abdullah Almoyad M; Binduhayyim RIH; Quadri SA; Gurumurthy V; Bavabeedu SS; Kuruniyan MS; Naseef PP; Mosaddad SA; Heboyan A
PLoS One; 2024; 19(3):e0300157. PubMed ID: 38483856
[TBL] [Abstract][Full Text] [Related]
6. Botulinum Toxin for Treating Temporomandibular Disorders: What is the Evidence?
Delcanho R; Val M; Guarda Nardini L; Manfredini D
J Oral Facial Pain Headache; 2022; 36(1):6-20. PubMed ID: 35298571
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study.
Ernberg M; Hedenberg-Magnusson B; List T; Svensson P
Pain; 2011 Sep; 152(9):1988-1996. PubMed ID: 21514731
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin in the management of temporomandibular disorders: a systematic review.
Thambar S; Kulkarni S; Armstrong S; Nikolarakos D
Br J Oral Maxillofac Surg; 2020 Jun; 58(5):508-519. PubMed ID: 32143934
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy of occlusal splint and botulinum toxin therapies in patients with temporomandibular disorders with sleep bruxism.
Hosgor H; Altindis S; Sen E
J Orofac Orthop; 2024 May; 85(Suppl 1):102-108. PubMed ID: 37843582
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta-analysis of randomized controlled trials.
Wei J; Zhu X; Yang G; Shen J; Xie P; Zuo X; Xia L; Han Q; Zhao Y
Brain Behav; 2019 Oct; 9(10):e01409. PubMed ID: 31541518
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials.
Chen YW; Chiu YW; Chen CY; Chuang SK
Int J Oral Maxillofac Surg; 2015 Aug; 44(8):1018-26. PubMed ID: 25920597
[TBL] [Abstract][Full Text] [Related]
12. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
Utomo E; Groen J; Blok BF
Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
[TBL] [Abstract][Full Text] [Related]
13. Unclear results for the use of botulinum toxin therapy for TMD pain.
Keenan JR
Evid Based Dent; 2015 Dec; 16(4):122. PubMed ID: 26680526
[TBL] [Abstract][Full Text] [Related]
14. Assessing change in functional outcomes and quality of life in myogenic temporomandibular disorders undergoing botulinum toxin injection: A before and after comparison.
Hosgor H; Coskunses FM; Altindis S
J Stomatol Oral Maxillofac Surg; 2023 Sep; 124(4):101434. PubMed ID: 36914004
[TBL] [Abstract][Full Text] [Related]
15. Effect of multiple injections of botulinum toxin into painful masticatory muscles on bone density in the temporomandibular complex.
Raphael KG; Janal MN; Tadinada A; Santiago V; Sirois DA; Lurie AG
J Oral Rehabil; 2020 Nov; 47(11):1319-1329. PubMed ID: 32885475
[TBL] [Abstract][Full Text] [Related]
16. Clinical Efficacy of Botulinum Toxin in the Treatment of Plantar Fasciitis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Acosta-Olivo C; Simental-Mendía LE; Vilchez-Cavazos F; Peña-Martínez VM; Elizondo-Rodíguez J; Simental-Mendía M
Arch Phys Med Rehabil; 2022 Feb; 103(2):364-371.e2. PubMed ID: 34688605
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of botulinum A toxin for the treatment of chronic peripheral neuropathic pain: A systematic review of randomized controlled trials and meta-analysis.
Hary V; Schitter S; Martinez V
Eur J Pain; 2022 May; 26(5):980-990. PubMed ID: 35293078
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of botulinum toxin in the management of patients with temporomandibular disorders and bruxism.
Patel J; Cardoso JA; Mehta S
Br Dent J; 2019 May; 226(9):667-672. PubMed ID: 31076698
[TBL] [Abstract][Full Text] [Related]
19. The hierarchy of different treatments for myogenous temporomandibular disorders: a systematic review and network meta-analysis of randomized clinical trials.
Al-Moraissi EA; Conti PCR; Alyahya A; Alkebsi K; Elsharkawy A; Christidis N
Oral Maxillofac Surg; 2022 Dec; 26(4):519-533. PubMed ID: 34674093
[TBL] [Abstract][Full Text] [Related]
20. The use of botulinum toxin-a in the treatment of muscular temporomandibular joint disorders.
Sipahi Calis A; Colakoglu Z; Gunbay S
J Stomatol Oral Maxillofac Surg; 2019 Sep; 120(4):322-325. PubMed ID: 30807862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
